ACCA Stock Overview
Acacia Diversified Holdings, Inc. engages in the extraction and processing of high-CBD/low-THC content medical grade hemp oils from medical hemp plants in the United States. More details
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Acacia Diversified Holdings, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.000001 |
52 Week High | US$0.0001 |
52 Week Low | US$0.000001 |
Beta | 0 |
11 Month Change | 0% |
3 Month Change | n/a |
1 Year Change | -99.00% |
33 Year Change | -99.99% |
5 Year Change | -100.00% |
Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
ACCA | US Pharmaceuticals | US Market | |
---|---|---|---|
7D | 0% | 3.4% | 1.6% |
1Y | -99.0% | 14.2% | 32.3% |
Return vs Industry: ACCA underperformed the US Pharmaceuticals industry which returned 13.1% over the past year.
Return vs Market: ACCA underperformed the US Market which returned 25.7% over the past year.
Price Volatility
ACCA volatility | |
---|---|
ACCA Average Weekly Movement | n/a |
Pharmaceuticals Industry Average Movement | 10.0% |
Market Average Movement | 6.3% |
10% most volatile stocks in US Market | 16.2% |
10% least volatile stocks in US Market | 3.1% |
Stable Share Price: ACCA has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine ACCA's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1984 | n/a | Jeffery Bearden | www.acaciadiversifiedholdings.com |
Acacia Diversified Holdings, Inc. engages in the extraction and processing of high-CBD/low-THC content medical grade hemp oils from medical hemp plants in the United States. The company is also involved in the research and development of botanicals endocannabinoid nutraceuticals product line; and retail and wholesale distribution of medicinal hemp products and dietary supplements. In addition, it offers consumer products under the EUFLORIA brand name for the distribution channels.
Acacia Diversified Holdings, Inc. Fundamentals Summary
ACCA fundamental statistics | |
---|---|
Market cap | US$48.00 |
Earnings (TTM) | -US$1.17m |
Revenue (TTM) | US$519.22k |
0.0x
P/S Ratio0.0x
P/E RatioIs ACCA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
ACCA income statement (TTM) | |
---|---|
Revenue | US$519.22k |
Cost of Revenue | US$387.48k |
Gross Profit | US$131.75k |
Other Expenses | US$1.30m |
Earnings | -US$1.17m |
Last Reported Earnings
Jun 30, 2020
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did ACCA perform over the long term?
See historical performance and comparison